The Future of mHealth

Antony Rix

Dr. Antony Rix is a Senior Consultant in the Communications and Wireless group at TTP, Europe’s leading independent technology consultancy and product development company. He has led projects in areas including mobile TV, phone apps, network planning, and novel short-range and wide area wireless technologies. Antony is currently engaged in business development, programme management and regulatory planning in wireless healthcare, mHealth and in safety-related radio systems.

Before he joined TTP in 2004, Antony worked at BT’s Research Laboratories and then co-founded Psytechnics, a successful start-up company developing quality of service and network monitoring software.

Antony has a Ph.D. from the University of Edinburgh and a Masters in Engineering from the University of Cambridge. He is a member of the American Telemedicine Association, Institute of Engineering and Technology and Audio Engineering Society, and he co-chairs the Cambridge Wireless Special Interest Group on Connected Devices. For more information please visit www.ttp.com


Chris Isaacs

Chris is a Connected Health specialist at Alere, a global provider of diagnostic equipment, services and solutions. Alere’s vision of Connected Health is to give people the tools to confidently manage their own health, no matter where they are. Chris has 10 years of experience in mobile communications from large multi-nationals to pre-funded start-ups and has spent the last few years with Alere with a focus on mobile health.

During his time with Alere Chris has been responsible for the creation and launch of a range of new products and services including Alere Data Point, a service which is now used by numerous Governments, Ministries of Health and Non-Government Organisations around the world in the fight against HIV. Data Point is an example of the coming together of mobile communications and healthcare to enhance the lives of millions of people.


Matt Hunt

Matt Hunt is the CEO of Panaram, an enterprise application solutions provider who specialise in Unified Communications mobile technology. Using agile and responsive development Panaram develop innovative mobile enterprise and communication solutions for global businesses such as Mitel, Zetacom, Wonefone & the University Medical Center Utrecht.

Panaram has undertaken ground breaking communications work in the healthcare sector which has included mobile projects to optimise the communication between 11,000 staff in the Netherlands’ largest public healthcare instituion. Panaram’s services include application roadmap planning, product design, development, provisioning, licensing and analytics.


Andy Stopford

Andy is the Technical Director at Havas Lynx and has over 16 years experience leading teams to deliver pioneering software solutions that enable business goals to be achieved. With experience drawn from the e-commerce, financial, insurance, banking and healthcare sectors he is committed to creating quality software that adheres to best practices and delivers solutions that are robust and help clients achieve business goals.

Andy is a software engineer by trade and is a published book author and keen writer with 200 magazine and journal articles over his career. He has a great depth and breadth of knowledge in a variety of technologies and is passionate about all things software engineering


Gary Birks

As Business Development Director for Dell’s Healthcare and Life Sciences business Gary is responsible for developing ‘services centric healthcare technology solutions to enable information at the point of care’. Gary has over 16 years of healthcare IM&T experience within both the public and private sector including working as a consultant at the Department of Health and as Head of IM&T at NHS Enfield Primary Care Trust. Gary is currently studying for a MSc in Health Informatics at the University of Central Lancashire.


Dr Farid Khan – Panel Chair

Dr. Farid Khan is a Life Sciences entrepreneur. He began his career in drug discovery at GlaxoSmithKline and then obtained a PhD in ‘fluorescent proteins’ from The University of Cambridge. Thereafter, he was employed by The University of Manchester and became a leader of the Molecular Biotechnology Group in 2010, following industrial funding by the Lonza Innovation for Future Technologies (LIFT) award. These interdisciplinary subjects would later enable him to provide solutions for major human diseases in the UK and the Developing World.

In 2011, Dr. Khan co-founded a contract research company, Protein Technologies Ltd which also develop ‘in vivo’ diagnostic agents for cancer and novel ‘time, temperature and product identification’ labels for pharmaceutical medication. In 2012, Dr. Khan formed PharmaKure Ltd, a spin out from The University of Manchester using a pioneering ‘drug repositioning approach’ namely the use of old drugs for other indications. These include: a drug for Alzheimer’s disease, which affects more than 35 million patients worldwide; a drug for malaria which infects more than 219 million persons a year and is one of the biggest killers of children in the world; and he is developing novel treatments for ‘incurable’ rare genetic diseases such Alkaptonurea with The Welcome Trust, giving hope to suffers of this debilitating disease. Dr. Khan has been awarded several Technology Strategy Board (TSB) grants totalling over £3M funding for technological innovation. The TSB is the UK government’s foremost agency which supports innovation and enterprise. But Dr. Khan’s work in medicine does not stop him working in other disciplines. His team has invented water sterilisation devices at low cost, which can be used to disinfect water making it safe for drinking. The devices were led to two Bill Gates Foundation awards for water sanitation for use in the developed world. Every 15 seconds, a child dies from water-related diseases.

In 2013, Dr. Khan was shortlisted by BioNow as one of the most promising technologists in the North of England. He has been interviewed by The Guardian and by Bloomberg and holds a research associate position at Peterhouse College, University of Cambridge. More recently, Dr. Khan’s most recent venture is eLucid mHealth Ltd, which is engaged in mobile healthcare, namely integrating a number of technologies; linking patient adherence to medication and companion diagnostics. He believes healthcare in the future will link medical devices/ pharmaceutical packaging with smartphones; whereby the smartphones will be the only interface with patients and healthcare professionals.